ROCKET PHARMACEUTICALS, INC.
For the period ended Jun 30, 2026. Filed Aug 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Investing Activities
During the six months ended June 30, 2026, net cash provided by investing activities was $231.8 million, primarily resulting from net proceeds of $178.2 million from the sale of the PRV, $117.3 million from the maturities of investments, offset by purchases of investments of $63.5 million, and purchases of property and equipment of $0.1 million.
During the six months ended June 30, 2025, net cash used by investing activities was $26.3 million, primarily resulting from proceeds of $166.8 million from the maturities of investments, offset by purchases of investments of $192.6 million, and purchases of property and equipment of $0.4 million.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.